Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
US-2024352069-A1 · Oct 24, 2024 · US
US9663554B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9663554-B2 |
| Application number | US-201514857661-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 17, 2015 |
| Priority date | Sep 19, 2014 |
| Publication date | May 30, 2017 |
| Grant date | May 30, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Multifunctional molecular weight protein ladders and methods of making thereof are disclosed herein that are useful for determining the molecular weight of a test protein and/or the relative mass or amount of the test protein in a protein separation assay, such as gel electrophoresis or western blotting. Also included are compounds of Formula I (e.g., mono acetylated MP-11 NHS ester) that may be used to label purified proteins of the protein ladder. The MP-11 label protein ladder can be detected on a blotting membrane by exposing the microperoxidase to a suitable substrate, such as a chromogenic substrate or a chemiluminescent substrate.
Opening claim text (preview).
What is claimed is: 1. A protein standard, said protein standard comprising a plurality of purified proteins having differing molecular weights; and wherein one or more proteins from the plurality of purified proteins is covalently linked to a mono microperoxidase N-hydroxy succinimidyl (NHS) ester of the formula: wherein n is 0-10, and the covalent linkage is between an amine from the one or more proteins and the N-hydroxy succinimidyl (NHS) ester group of the mono microperoxidase N-hydroxy succinimidyl (NHS) ester. 2. The protein standard of claim 1 , wherein the protein standard comprises at least 5 different purified proteins. 3. The protein standard of claim 1 , wherein the protein standard comprises at least 10 different purified proteins. 4. The protein standard of claim 1 , wherein the range of molecular weights of the protein standard is about 5 kDa to about 280 kDa. 5. The protein standard of claim 1 , wherein the range of molecular weights of the protein standard is about 8 kDa to about 260 kDa. 6. The protein standard of claim 1 , wherein at least 2 of the purified proteins of the protein standard are covalently linked to the mono microperoxidase NHS ester. 7. The protein standard of claim 1 , wherein at least 3 of the purified proteins of the protein standard are covalently linked to the mono microperoxidase NHS ester. 8. The protein standard of claim 1 , wherein at least 4 of the purified proteins of the protein standard are covalently linked to the mono microperoxidase NHS ester. 9. The protein standard of claim 1 , wherein at least 5 of the purified proteins of the protein standard are covalently linked to the mono microperoxidase NHS ester. 10. The protein standard of claim 1 , wherein at least 10 of the purified proteins of the protein standard are covalently linked to the mono microperoxidase NHS ester. 11. The protein standard of claim 1 , wherein the mono microperoxidase NHS ester is a mono MP-11 NHS ester of formula Ia:
having 5 to 11 amino acids · CPC title
involving peroxidase · CPC title
with fluorescent label · CPC title
Porphyrin- or corrin-ring-containing peptides · CPC title
Electrophoretic profiling, e.g. for proteome analysis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.